7
Apr
2025
Leaving A Mark On Patients
Leading a nonprofit that helps kids and families with terrible diseases requires a certain ability to roll with the punches. That feeling hit last week when I heard about Peter Marks’ forced resignation as Director of the FDA’s Center for Biologics Evaluation and Research (CBER). Here was a scientific champion of innovative cell and gene therapies at the FDA. He... Read More